2024 RxDC Reporting Due June 1, 2024
Group health plan sponsors and health insurance issuers are required to submit an annual prescription drug data collection report (“RxDC reporting”) to the Centers for Medicare and Medicaid Services (“CMS”), detailing certain prescription drug benefits and other health care spending data respective of the group health plans they sponsor. Respecting the 2023 calendar year reporting cycle, these informational disclosures must be provided to CMS on or before Saturday, June 1, 2024.
Employer Action Items
As of the date of receipt of this BRCC Alert, if you have not received RxDC reporting related communications from your health insurance carriers, your TPA, or your PBM, please consider the following actions:
- Contact your vendors. Identify whether, and to what extent, your vendors may require additional information from you to perform the federal reporting obligations on a timely basis. Many carriers, TPAs, and PBMs have either voluntarily or contractually agreed to make these disclosures on behalf of the employer sponsored plans they insure and/or administer.
- Review your written agreements. The vendor agreements maintained with your vendors should contemplate the performance of the RxDC reporting obligations. If your written agreements are silent respecting the performance of these obligations, time is of the essence to assure that that your carriers and administrators will prepare and submit these disclosures on your behalf.
- Provide Plan-specific Information to your Vendors. Your vendors may require additional plan or enrollee-specific information (such as group health plan premiums, prescription drug pricing, and participant enrollment data) in order to perform the RxDC reporting obligations. In many instances, vendors are emailing informational surveys to employers requesting this information. Closely monitor your email for the arrival of these important vendor surveys and upon receipt of any vendor survey or informational request, respond on an accurate and timely basis.
Note: Employers with self-funded plans should confirm their TPA or PBM (as relevant) is preparing and submitting these disclosures, because ultimately, it is the employer plan sponsor who is charged to assure compliance with the RxDC reporting obligations.
Regulatory Overview
Summary of Requirements:
“Under Section 204 (of Title II, Division BB) of the https://www.congress.gov/116/bills/hr133/BILLS-116hr133enr.pdf (CAA), insurance companies and employer-based health plans must submit information about prescription drugs and health care spending. This data submission is called the RxDC report. The Rx stands for prescription drug and the DC stands for data collection. The RxDC report isn’t only about prescription drugs. It also collects information about spending on health care services and premium paid by members and employers.
The RxDC report is comprised of several files, including those that require specific plan-level information (such as plan year beginning and end dates as well as enrollment and premium data) and detailed information about pharmacy and medical benefits.
Most employers contract with third parties, such as issuers, third-party administrators (TPAs) and pharmacy benefit managers (PBMs), to submit RxDC reports on behalf of their health plans. Employers may even work with multiple third parties to complete the RxDC report for their health plans. CMS will consider a health plan’s submission complete if it receives all required files, regardless of who or what entity submits them.”
Primary Filing Resources:
- RxDC reporting instructions (PDF)
- RxDC templates and data dictionary (ZIP)
- RxDC drug name and therapeutic class crosswalk (XLSX)
- RxDC data validations (XLSX)
Additional Employer Resources:
